BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li CM, Haratipour P, Lingeman RG, Perry JJP, Gu L, Hickey RJ, Malkas LH. Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells 2021;10:2908. [PMID: 34831131 DOI: 10.3390/cells10112908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Ye X, Li J, Liu Z, Sun X, Wei D, Song L, Wu C. Peptide mediated therapy in fibrosis: Mechanisms, advances and prospects. Biomedicine & Pharmacotherapy 2023;157:113978. [DOI: 10.1016/j.biopha.2022.113978] [Reference Citation Analysis]
2 Nguyen T, Guo R, Chai J, Wu J, Liu J, Chen X, Abdel-Rahman MA, Xia H, Xu X. Smp24, a Scorpion-Venom Peptide, Exhibits Potent Antitumor Effects against Hepatoma HepG2 Cells via Multi-Mechanisms In Vivo and In Vitro. Toxins (Basel) 2022;14:717. [PMID: 36287985 DOI: 10.3390/toxins14100717] [Reference Citation Analysis]
3 Belluomo R, Khodaei A, Yavari SA. Additively Manufactured Bi-functionalized Bioceramics for Reconstruction of Bone Tumor Defects. Acta Biomater 2022:S1742-7061(22)00518-9. [PMID: 36028198 DOI: 10.1016/j.actbio.2022.08.042] [Reference Citation Analysis]
4 Abdulmalek S, Mostafa N, Gomaa M, El‑kersh M, Elkady AI, Balbaa M. Bee venom-loaded EGFR-targeting peptide-coupled chitosan nanoparticles for effective therapy of hepatocellular carcinoma by inhibiting EGFR-mediated MEK/ERK pathway. PLoS ONE 2022;17:e0272776. [DOI: 10.1371/journal.pone.0272776] [Reference Citation Analysis]
5 Hailing T, Yonghong P, Yufeng Z, Haitao T. Challenges for the application of EGFR-targeting peptide GE11 in tumor diagnosis and treatment. J Control Release 2022;349:592-605. [PMID: 35872181 DOI: 10.1016/j.jconrel.2022.07.018] [Reference Citation Analysis]
6 Al-Rabia MW, Alhakamy NA, Rizg WY, Alghaith AF, Ahmed OAA, Fahmy UA. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Deliv 2022;29:807-20. [PMID: 35266425 DOI: 10.1080/10717544.2022.2048133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
7 Li Y, Chen Z, Gu L, Duan Z, Pan D, Xu Z, Gong Q, Li Y, Zhu H, Luo K. Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opin Drug Deliv 2022. [PMID: 35244503 DOI: 10.1080/17425247.2022.2050211] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Damanskienė E, Balnytė I, Valančiūtė A, Alonso MM, Preikšaitis A, Stakišaitis D. The Different Temozolomide Effects on Tumorigenesis Mechanisms of Pediatric Glioblastoma PBT24 and SF8628 Cell Tumor in CAM Model and on Cells In Vitro. Int J Mol Sci 2022;23:2001. [PMID: 35216113 DOI: 10.3390/ijms23042001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]